Votes: NJ S680 | 2022-2023 | Regular Session

Bill Title: Prohibits pre-approval or precertification of cancer treatments, tests, procedures and prescription drugs covered under health benefits or prescription drug benefits plans.

Spectrum: Partisan Bill (Republican 2-0)

Status: (Introduced - Dead) 2022-01-11 - Introduced in the Senate, Referred to Senate Commerce Committee [S680 Detail]

Text: Latest bill text (Introduced) [HTML]

Voting Records

ChamberVoteDateYeaNayNVAbsTotalResultSourceView
No roll call record information currently on file.
States not producing parsable votes may be available as images in Supplemental Documents.

Social Comments on NJ S680

feedback